Who owns Revolution Medicines, Inc. (RVM)? Elite investor 13F holders

8 tracked elite investors reported holding Revolution Medicines, Inc as of 2026-06-30, including Alphabet, Caligan Partners, D.E. Shaw, Gotham Asset Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

8 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
AlphabetREVOLUTION MEDICINES INCSHARE2026-06-302026-08-07 00:00:00551842806.00 USD2946619.000000SharesreduceOriginal filing
Caligan PartnersREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:00367404968.00 USD1961795.000000SharesaddOriginal filing
D.E. ShawREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:002322272.00 USD12400.000000SharesreduceOriginal filing
Duquesne Family OfficeREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
Gotham Asset ManagementREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:0022605071.00 USD120702.000000SharesreduceOriginal filing
D.E. ShawREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:0014855243.00 USD1580345.000000SharesholdOriginal filing
Tudor InvestmentREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:002996480.00 USD16000.000000SharesreduceOriginal filing
Anson FundsREVOLUTION MEDICINES INCSHARE2026-06-302026-08-13 00:00:003745600.00 USD20000.000000Shares—Original filing
Oaktree Capital ManagementREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:001442773.00 USD1150000.000000PrincipalbuyOriginal filing
Renaissance Technologies LLCREVOLUTION MEDICINES INCSHARE2026-06-302026-08-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
Ancora Advisors / Ancora HoldingsREVOLUTION MEDICINES INCSHARE2026-06-302026-08-14 00:00:003746.00 USD20.000000SharesreduceOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown